# Yunhong Green Cti LTD.: financial statements, quarterly

YHGJ · Nasdaq · CIK 1042187 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/yhgj.md) · [Financials](/companies/yhgj/financials.md) · [Filings](/companies/yhgj/filings.md) · [Insiders](/companies/yhgj/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/yhgj/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,923](/filings/0001493152-24-044140.md) | [6,771 d](/filings/0001641172-25-004622.md) | [4,894](/filings/0001641172-25-011658.md) | [4,354](/filings/0001493152-25-011965.md) | [2,540](/filings/0001493152-25-022194.md) | [6,165 d](/filings/0001493152-26-012156.md) | [4,802](/filings/0001493152-26-022647.md) | [5,457](/filings/0001493152-26-036497.md) | [2,953](/filings/0001493152-25-022194.md) | [6,493 d](/filings/0001493152-26-012156.md) | [6,154](/filings/0001493152-26-022647.md) | [3,900](/filings/0001493152-26-036497.md) |
| Cost of revenue | $k | [1,903](/filings/0001493152-24-044140.md) | [5,174 d](/filings/0001641172-25-004622.md) | [3,999](/filings/0001641172-25-011658.md) | [3,662](/filings/0001493152-25-011965.md) | [2,560](/filings/0001493152-25-022194.md) | [4,132 d](/filings/0001493152-26-012156.md) | [3,936](/filings/0001493152-26-022647.md) | [4,479](/filings/0001493152-26-036497.md) | [2,886](/filings/0001493152-25-022194.md) | [4,814 d](/filings/0001493152-26-012156.md) | [5,138](/filings/0001493152-26-022647.md) | [3,362](/filings/0001493152-26-036497.md) |
| Gross profit | $k | [20.0](/filings/0001493152-24-044140.md) | [1,597 d](/filings/0001641172-25-004622.md) | [895](/filings/0001641172-25-011658.md) | [692](/filings/0001493152-25-011965.md) | [(20.0)](/filings/0001493152-25-022194.md) | [2,033 d](/filings/0001493152-26-012156.md) | [866](/filings/0001493152-26-022647.md) | [978](/filings/0001493152-26-036497.md) | [67.0](/filings/0001493152-25-022194.md) | [1,679 d](/filings/0001493152-26-012156.md) | [1,016](/filings/0001493152-26-022647.md) | [538](/filings/0001493152-26-036497.md) |
| Operating income | $k | [(829)](/filings/0001493152-24-044140.md) | [708 d](/filings/0001641172-25-004622.md) | [(353)](/filings/0001641172-25-011658.md) | [(171)](/filings/0001493152-25-011965.md) | [(991)](/filings/0001493152-25-022194.md) | [902 d](/filings/0001493152-26-012156.md) | [(178)](/filings/0001493152-26-022647.md) | [19.0](/filings/0001493152-26-036497.md) | [(983)](/filings/0001493152-25-022194.md) | [(908) d](/filings/0001493152-26-012156.md) | [(98.0)](/filings/0001493152-26-022647.md) | [(320)](/filings/0001493152-26-036497.md) |
| Interest expense | $k | [124](/filings/0001493152-23-040227.md) | [207 d](/filings/0001493152-24-011910.md) | [218](/filings/0001641172-25-011658.md) | [236](/filings/0001493152-25-011965.md) | [201](/filings/0001493152-25-022194.md) | [207 d](/filings/0001493152-26-012156.md) | [237](/filings/0001493152-26-022647.md) | [227](/filings/0001493152-26-036497.md) | [198](/filings/0001493152-25-022194.md) | [216 d](/filings/0001493152-26-012156.md) | [242](/filings/0001493152-26-022647.md) | [225](/filings/0001493152-26-036497.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(967)](/filings/0001493152-24-044140.md) | [485 d](/filings/0001641172-25-004622.md) | [(576)](/filings/0001493152-25-022194.md) | [(414)](/filings/0001493152-25-022194.md) | [(1,193)](/filings/0001493152-25-022194.md) | [683 d](/filings/0001493152-26-012156.md) | [(416)](/filings/0001493152-26-036497.md) | [(185)](/filings/0001493152-26-036497.md) | [(811)](/filings/0001493152-25-022194.md) | [(1,118) d](/filings/0001493152-26-012156.md) | [(341)](/filings/0001493152-26-036497.md) | [(543)](/filings/0001493152-26-036497.md) |
| Diluted EPS | $ per share | [(0.05)](/filings/0001493152-24-044140.md) | not reported | [(0.03)](/filings/0001641172-25-011658.md) | [0.02](/filings/0001493152-25-011965.md) | [(0.47)](/filings/0001493152-25-022194.md) | not reported | [(0.18)](/filings/0001493152-26-022647.md) | [(0.09)](/filings/0001493152-26-036497.md) | [(0.31)](/filings/0001493152-25-022194.md) | not reported | [(0.15)](/filings/0001493152-26-022647.md) | [(0.22)](/filings/0001493152-26-036497.md) |
| Basic EPS | $ per share | [(0.05)](/filings/0001493152-24-044140.md) | not reported | [(0.03)](/filings/0001641172-25-011658.md) | [0.02](/filings/0001493152-25-011965.md) | [(0.47)](/filings/0001493152-25-022194.md) | not reported | [(0.18)](/filings/0001493152-26-022647.md) | [(0.09)](/filings/0001493152-26-036497.md) | [(0.31)](/filings/0001493152-25-022194.md) | not reported | [(0.15)](/filings/0001493152-26-022647.md) | [(0.22)](/filings/0001493152-26-036497.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001493152-23-040227.md) | [0.9](/filings/0001641172-25-004622.md) | [0.0](/filings/0001493152-24-038100.md) | [0.0](/filings/0001493152-24-038294.md) | [0.0](/filings/0001493152-24-044140.md) | [0.2](/filings/0001493152-26-012156.md) | [0.2](/filings/0001641172-25-011658.md) | [0.0](/filings/0001493152-25-011965.md) | [0.4](/filings/0001493152-25-022194.md) | [0.1](/filings/0001493152-26-036497.md) | [0.2](/filings/0001493152-26-022647.md) | [0.3](/filings/0001493152-26-036497.md) |
| Current assets | $m | [9.9](/filings/0001493152-23-040227.md) | [13.0](/filings/0001641172-25-004622.md) | [12.6](/filings/0001493152-24-038100.md) | [11.2](/filings/0001493152-24-038294.md) | [10.4](/filings/0001493152-24-044140.md) | [14.5](/filings/0001493152-26-012156.md) | [13.8](/filings/0001641172-25-011658.md) | [12.2](/filings/0001493152-25-011965.md) | [11.9](/filings/0001493152-25-022194.md) | [15.1](/filings/0001493152-26-036497.md) | [14.5](/filings/0001493152-26-022647.md) | [11.8](/filings/0001493152-26-036497.md) |
| Total assets | $m | [14.3](/filings/0001493152-23-040227.md) | [17.2](/filings/0001641172-25-004622.md) | [16.7](/filings/0001493152-24-038100.md) | [21.6](/filings/0001493152-24-038294.md) | [20.6](/filings/0001493152-24-044140.md) | [25.6](/filings/0001493152-26-012156.md) | [24.6](/filings/0001641172-25-011658.md) | [22.7](/filings/0001493152-25-011965.md) | [22.2](/filings/0001493152-25-022194.md) | [22.5](/filings/0001493152-26-036497.md) | [21.6](/filings/0001493152-26-022647.md) | [18.6](/filings/0001493152-26-036497.md) |
| Current liabilities | $m | [8.4](/filings/0001493152-23-040227.md) | [10.1](/filings/0001641172-25-004622.md) | [8.2](/filings/0001493152-24-038100.md) | [7.5](/filings/0001493152-24-038294.md) | [7.8](/filings/0001493152-24-044140.md) | [11.4](/filings/0001493152-26-012156.md) | [10.8](/filings/0001641172-25-011658.md) | [8.2](/filings/0001493152-25-011965.md) | [8.2](/filings/0001493152-25-022194.md) | [10.7](/filings/0001493152-26-036497.md) | [10.4](/filings/0001493152-26-022647.md) | [8.4](/filings/0001493152-26-036497.md) |
| Total liabilities | $m | [11.3](/filings/0001493152-23-040227.md) | [13.5](/filings/0001641172-25-004622.md) | [11.5](/filings/0001493152-24-038100.md) | [10.5](/filings/0001493152-24-038294.md) | [10.7](/filings/0001493152-24-044140.md) | [14.9](/filings/0001493152-26-012156.md) | [14.1](/filings/0001641172-25-011658.md) | [11.4](/filings/0001493152-25-011965.md) | [11.6](/filings/0001493152-25-022194.md) | [13.9](/filings/0001493152-26-036497.md) | [13.4](/filings/0001493152-26-022647.md) | [10.9](/filings/0001493152-26-036497.md) |
| Long-term debt | $m | not reported | [0.5](/filings/0001493152-24-011910.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | [6.5](/filings/0001493152-24-011910.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2.9](/filings/0001493152-24-044140.md) | [3.7](/filings/0001493152-26-012156.md) | [5.3](/filings/0001493152-25-022194.md) | [11.1](/filings/0001493152-25-022194.md) | [9.9](/filings/0001493152-25-022194.md) | [10.7](/filings/0001493152-26-036497.md) | [10.5](/filings/0001493152-26-036497.md) | [11.4](/filings/0001493152-26-036497.md) | [10.5](/filings/0001493152-25-022194.md) | [8.6](/filings/0001493152-26-036497.md) | [8.3](/filings/0001493152-26-036497.md) | [7.7](/filings/0001493152-26-036497.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [919 d](/filings/0001493152-24-044140.md) | [(780) d](/filings/0001641172-25-004622.md) | [(767)](/filings/0001641172-25-011658.md) | [875 d](/filings/0001493152-25-011965.md) | [754 d](/filings/0001493152-25-022194.md) | [(2,136) d](/filings/0001493152-26-012156.md) | [970](/filings/0001493152-26-022647.md) | [744 d](/filings/0001493152-26-036497.md) | [586 d](/filings/0001493152-25-022194.md) | [(2,472) d](/filings/0001493152-26-012156.md) | [236](/filings/0001493152-26-022647.md) | [2,299 d](/filings/0001493152-26-036497.md) |
| Capital expenditure | $k | [42.0 d](/filings/0001493152-24-044140.md) | [85.0 d](/filings/0001641172-25-004622.md) | [154](/filings/0001641172-25-011658.md) | [120 d](/filings/0001493152-25-011965.md) | [28.0 d](/filings/0001493152-25-022194.md) | [29.0 d](/filings/0001641172-25-004622.md) | [20.0](/filings/0001493152-26-022647.md) | [22.0 d](/filings/0001493152-26-036497.md) | [26.0 d](/filings/0001493152-25-022194.md) | not reported | [27.0](/filings/0001493152-26-022647.md) | [3.0 d](/filings/0001493152-26-036497.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.3](/filings/0001493152-23-040227.md) | [17.7](/filings/0001493152-24-038100.md) | [20.0](/filings/0001493152-24-038294.md) | [20.1](/filings/0001493152-24-044140.md) | [20.8](/filings/0001641172-25-011658.md) | [20.9](/filings/0001493152-25-011965.md) | [2.6](/filings/0001493152-25-022194.md) | [2.6](/filings/0001493152-26-022647.md) | [2.6](/filings/0001493152-26-036497.md) | [2.7](/filings/0001493152-25-022194.md) | [2.6](/filings/0001493152-26-022647.md) | [2.6](/filings/0001493152-26-036497.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,609,244 at 2026-08-07, from the cover of the [10-Q filed 2026-08-07](/filings/0001493152-26-036497.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.